Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Not Yet Recruiting

A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

NCT07607925

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: GSK Investigational Site Canton, Ohio, United States

GSK Investigational Site Toronto, Ontario, Canada

GSK Investigational Site Tokyo, Japan

View Trial Details

Not Yet Recruiting

TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer

NCT07652983

Conditions: Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma

NCT07612787

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Centre Hospitalier Universitaire Amiens, France

Centre Hospitalier Universitaire Angers, France

Centre Hospitalier Universitaire Annecy, France

Centre Hospitalier D'Argenteuil Argenteuil, France

View all 30 locations

View Trial Details

Not Yet Recruiting

Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation

NCT07382024

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation Ablation, +15 more
Locations: National Taiwan University Hospital Cardiovascular Center Taipei, Taiwan

View Trial Details

Not Yet Recruiting

Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

NCT07637929

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases

NCT07490275

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

NCT07636148

Conditions: Adenocarcinoma, Bone Cancer Metastatic, Bone Cancer Tumor, +46 more
Locations: Hospices Civils de Lyon - Hôpital Édouard Herriot Lyon, Auvergne-Rhône-Alpes, France

Assistance Publique Hopitaux de Paris - Hôpital Henri Mondor Créteil, Île-de-France Region, France

Leiden University Medical Center Leiden, South Holland, Netherlands

View Trial Details

Not Yet Recruiting

A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell Malignancies

NCT07628582

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell Lymphoma

NCT07622784

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

NCT07623798

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: ZhongShan Hospital FuDan University Shanghai, Shanghai Municipality, China

View Trial Details

Recurrence

Recurrence trial results

Related conditions